Not applicableActive Not RecruitingNCT03784248What this trial is testingMediterranean Visceral Leishmaniasis With Leishmania InfantumWho this might be right forLeishmaniasis Centre Hospitalier Universitaire de Nice 1,400
Not applicableStudy completedNCT05426577What this trial is testingEvaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of CureWho this might be right forVisceral Leishmaniasis Foundation for Innovative New Diagnostics, Switzerland 60
Large-scale testing (Phase 3)Study completedNCT01644682What this trial is testingReplacement of Insecticides to Control Visceral Leishmaniasis (VL)Who this might be right forCost-effective and Sustainable Vector Control Methods Will be Established to Reduce VL in India, Bangladesh and Nepal International Centre for Diarrhoeal Disease Research, Bangladesh 3,600
Not applicableActive Not RecruitingNCT04342715What this trial is testingAssess Immune Response Status in Patients Before and After Treatment for Visceral LeishmaniasisWho this might be right forVisceral Leishmaniasis University of York 216
Early research (Phase 1)Study completedNCT00486382What this trial is testingOpen-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in IndiaWho this might be right forVisceral LeishmaniasisPost-kala-azar Dermal Leishmaniasis Access to Advanced Health Institute (AAHI) 36
Post-approval studies (Phase 4)Study completedNCT03311607What this trial is testingSafety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in BangladeshWho this might be right forPost-kala-azar Dermal Leishmaniasis Medecins Sans Frontieres, Netherlands 280
Large-scale testing (Phase 3)Study completedNCT02193022What this trial is testingMiltefosine for Children With PKDLWho this might be right forPost Kala Azar Dermal Leishmaniasis International Centre for Diarrhoeal Disease Research, Bangladesh 80
Not applicableLooking for participantsNCT07783243What this trial is testingEx Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With LeishmaniasisWho this might be right forLeishmaniasis, CutaneousLeishmaniasisLeishmaniasis, Visceral+1 more Institute of Tropical Medicine, Belgium 90
Testing effectiveness (Phase 2)Study completedNCT00370825What this trial is testingCombination Chemotherapy for the Treatment of Indian Kala-AzarWho this might be right forVisceral Leishmaniasis Banaras Hindu University 200
Large-scale testing (Phase 3)Study completedNCT02011958What this trial is testingEfficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.Who this might be right forVisceral Leishmaniasis Drugs for Neglected Diseases 59
Large-scale testing (Phase 3)Study completedNCT00629031What this trial is testingAn Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral LeishmaniasisWho this might be right forVisceral Leishmaniasis Banaras Hindu University 329
Not applicableUnknownNCT05386875What this trial is testingEvaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in KenyaWho this might be right forVisceral Leishmaniasis Foundation for Innovative New Diagnostics, Switzerland 625
Early research (Phase 1)Study completedNCT02071758What this trial is testingPhase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult VolunteersWho this might be right forVisceral Leishmaniasis Access to Advanced Health Institute (AAHI) 39
Large-scale testing (Phase 3)Study completedNCT00876824What this trial is testingTo Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala AzarWho this might be right forLeishmaniasis, Visceral Bharat Serums and Vaccines Limited 500
Testing effectiveness (Phase 2)Study completedNCT05593666What this trial is testingA Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisWho this might be right forPrimary Visceral Leishmaniasis Drugs for Neglected Diseases 101
Not applicableStudy completedNCT04003532What this trial is testingLAMP Assay for the Diagnosis of Visceral LeishmaniasisWho this might be right forVisceral Leishmaniasis Prof. Dawit Wolday 500
Post-approval studies (Phase 4)UnknownNCT01566552What this trial is testingSingle Dose Liposomal Amphotericin B for Visceral LeishmaniasisWho this might be right forVisceral Leishmaniasis Banaras Hindu University 1,300
Not applicableStudy completedNCT01069198What this trial is testingA Community Trial for Visceral Leishmaniasis (VL)Who this might be right forVisceral Leishmaniasis International Centre for Diarrhoeal Disease Research, Bangladesh 200
Not applicableEnded earlyNCT03013673What this trial is testingPredicting Visceral Leishmaniasis in HIV Infected PatientsWho this might be right forLeishmaniasis, Visceral Institute of Tropical Medicine, Belgium 566
Not applicableStudy completedNCT05449717What this trial is testingIncidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South SudanWho this might be right forLeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis Epicentre 52